Measuring Depression in the Medically III
As Silverstone (1) and other investigators (2) point out, the DSM-III, IIIR, and IV defming criteria of depression have included symptoms that can be produced or obscured by physical illness and are not necessarily related to depression. For this reason, and possibly others, an estimate of the prevalence of depression in medical illness has been elusive. There has been a great range in estimates: for example, Lansky (3) found major depression in 5.3% ofhis sample of cancer patients, while Bukberg (4) found major depression in 42% of his sample of cancer patients. Studies of multiple sclerosis patients found the prevalence ofmajor depression to be 6% to 57% (5) . A study of Cushing's patients (6) found major depression in 83% of patients.
On face validity, one might expect differences in depression between illness groups related to the degree of disability (or "perceived loss") or impact by the disease on quality of life. However, in order to study this question in a meaningful way, there must first be agreement on valid measures of depression in the medically ill. Silverstone (1) and other investigators (7) suggest methods for valid measurement. These methods should be used uniformly in future research in this area. 65 The Problem ofDepression in the Medically III Studies repeatedly demonstrate an underestimation of depression in the medically ill by medical and other health care staff (1) . This fmding takes on major significance when one considers the following two points:
• depression in the medically ill exacerbates both morbidity and mortality (2);
• depression in the medically ill greatly increases the fmancial burden borne by the patient and by society (8) . Depression is likely to increase the risk of a self-perpetuating downward spiral involving decreasing self-care and poor progress in coping with the illness. Passive and active suicide attempts complicate this downward spiral.
Recent work in the area ofpsychoneuroendocrinology (9) and psychological factors affecting medical condition (10) documents the close link between mood states and illness. VanderKolk has stated, "It is thus no longer scientifically justifiable to make clear distinction between psychologic and biologic processes; rather we need to defme our understanding ofthe degree to which genetic, developmental, toxic and social factors converge to result in certain syndrome" (11) .
Psychiatric Interventions: Effective Treatments ofDepression for the Medically III
What gives these considerations even more import is that psychiatry has developed effective and practical treatments. Group psychotherapy, individual psychotherapy (12) , and pharmacotherapy (13) work, with reasonable cost, and have a beneficial impact on quality of life in medical illness. New developments in pharmacotherapy have been especially helpful in treating depression in physically compromised patients (e.g., cardiac dysfunction or renal dysfunction).
In summary, case fmding of depression in the medically ill is an area that needs more attention especially by the consultation-liaison psychiatrist, but also by others on the health care team. Depression in the medically ill is an important source of added morbidity and mortality, and most importantly, it can be treated.
